logo

Riding the Waves: A Guide to Investing in EYPT Stock

ELVT Stock

EyePoint Pharmaceuticals Inc’s stock has had a calm market performance. The 1-year high for the company’s stock was $30.99 on 02/08/24, and the lowest price during the same period was recorded at $3.26 on 04/12/23.

52-week price history of EYPT Stock

A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. EyePoint Pharmaceuticals Inc’s current trading price is -26.14% away from its 52-week high, while its distance from the 52-week low is 602.15%. The stock’s price range during this period has fluctuated between $3.26 and $30.99. Shares of the company, which operates in the Healthcare sector, recorded a trading volume of around 0.65 million for the day, which was evidently lower than the average daily volume of 0.96 million over the last three months.

Financial Performance and Market Capitalization

EyePoint Pharmaceuticals Inc (EYPT) has experienced a quarterly rise of 13.15% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.14B and boasts a workforce of 121 employees.

Moving average and trading volume data

Based on Barchart.com data, the company’s moving average over the 100-day period was 21.59, with a change in price of +16.20. Similarly, EyePoint Pharmaceuticals Inc recorded 1,371,892 in trading volume during the last 100 days, posting a change of +242.15%.

EYPT Debt-to-equity ratio analysis

The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for EYPT stands at 0.02. Similarly, the long-term debt-to-equity ratio is also 0.02.

EYPT Stock Stochastic Average

EyePoint Pharmaceuticals Inc’s raw stochastic average for the past 50 days is currently at 30.11%. This represents a fall from the raw stochastic average of the last 20 days, which was recorded at 76.37%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 57.84% and 42.67%, respectively.

EYPT Stock Price Performance Analysis

The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. This year’s metric has recorded a Price decrease of -0.95%. However, over the past six months, we’ve seen a weaker performance of 161.60%. The price of EYPT fallen by 0.35% over the last 30 days. And in the last five days, it has surged by 13.60%.